Flynn ST[Author] - Search Results

Year	Number of Results
1955	1
1993	1
2000	2
2005	1
2008	1
2009	1
2010	1
2017	1
2024	0

1

2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2.

Boyd HF, Flynn ST, Hickey DM, Ife RJ, Jones M, Leach CA, Macphee CH, Milliner KJ, Rawlings DA, Slingsby BP, Smith SA, Stansfield IG, Tew DG, Theobald CJ. Boyd HF, et al. Among authors: flynn st. Bioorg Med Chem Lett. 2000 Feb 21;10(4):395-8. doi: 10.1016/s0960-894x(00)00002-0. Bioorg Med Chem Lett. 2000. PMID: 10714508

2

Identification of a potent and selective 5-HT1B receptor antagonist.

Wyman PA, Marshall HR, Flynn ST, King RJ, Thompson M, Smith PW, Hadley MS, Price GW, Scott CM, Dawson LA. Wyman PA, et al. Among authors: flynn st. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4708-12. doi: 10.1016/j.bmcl.2005.07.085. Bioorg Med Chem Lett. 2005. PMID: 16153839

3

MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia.

Xu D, Ham AG, Tivis RD, Caylor ML, Tao A, Flynn ST, Economen PJ, Dang HK, Johnson RW, Culbertson VL. Xu D, et al. Among authors: flynn st. EBioMedicine. 2017 Dec;26:132-137. doi: 10.1016/j.ebiom.2017.11.015. Epub 2017 Nov 22. EBioMedicine. 2017. PMID: 29191560 Free PMC article.

4

Studies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands--part II.

Ward SE, Eddershaw P, Flynn ST, Gordon L, Lovell PJ, Moore SH, Scott CM, Smith PW, Thewlis KM, Wyman PA. Ward SE, et al. Among authors: flynn st. Bioorg Med Chem Lett. 2009 Jan 15;19(2):428-32. doi: 10.1016/j.bmcl.2008.11.052. Epub 2008 Nov 19. Bioorg Med Chem Lett. 2009. PMID: 19071020

5

The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.

Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F. Johnson DJ, et al. Among authors: flynn st. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5434-8. doi: 10.1016/j.bmcl.2010.07.097. Epub 2010 Jul 30. Bioorg Med Chem Lett. 2010. PMID: 20709550

6

N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2.

Boyd HF, Fell SC, Flynn ST, Hickey DM, Ife RJ, Leach CA, Macphee CH, Milliner KJ, Moores KE, Pinto IL, Porter RA, Rawlings DA, Smith SA, Stansfield IG, Tew DG, Theobald CJ, Whittaker CM. Boyd HF, et al. Among authors: flynn st. Bioorg Med Chem Lett. 2000 Nov 20;10(22):2557-61. doi: 10.1016/s0960-894x(00)00510-2. Bioorg Med Chem Lett. 2000. PMID: 11086729

7

Cyclic nucleotide phosphodiesterase inhibition by imidazopyridines: analogues of sulmazole and isomazole as inhibitors of the cGMP specific phosphodiesterase.

Coates WJ, Connolly B, Dhanak D, Flynn ST, Worby A. Coates WJ, et al. Among authors: flynn st. J Med Chem. 1993 May 14;36(10):1387-92. doi: 10.1021/jm00062a011. J Med Chem. 1993. PMID: 8388468

8

Primary closure of the bladder with suprapubic prostatectomy.

FLYNN ST, RAWLING JC. FLYNN ST, et al. Postgrad Semin Am Urol Assoc North Cent. 1955:145-6. Postgrad Semin Am Urol Assoc North Cent. 1955. PMID: 13359359 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year